Sample size nomograms for interpreting negative clinical studies.
about
Comparison of effects of two hemoglobin-based O(2) carriers on intestinal integrity and microvascular leakageSodium selenite reduces hemoglobin-induced venular leakage in the rat mesenteryA randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenonSweat gland function in Sjögren's syndrome.Comparison of Pharmaceutical Calculations Learning Outcomes Achieved Within a Traditional Lecture or Flipped Classroom AndragogyAzithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistanceClinical research: the pharmaceutical industry's point of viewA randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee.Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial.Low-molecular-weight heparin for the treatment of patients with mechanical heart valves.Determination of the clinical importance of study results.Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.Efficacy of alcohol-based hand rinses under frequent-use conditions.Nebulised beclomethasone dipropionate in preschool asthmaTreatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trialAll that glisters...how to assess the 'value' of a scientific paper.Efficacy of a single dose of furazolidone for treatment of cholera in children.Getting started in clinical nutrition research.Increased dietary sodium chloride in patients treated with antihypertensive drugs.The design of clinical trials with antibiotics.The implications for Europe of revised FDA guidelines for clinical trials with anti-infective agents.Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.Lipid-based Nose Ointment for Allergic Rhinitis.Adjuvant therapy of cutaneous malignant melanoma: a critical review.Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported.Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?Comparison of ear to rectal temperature measurements in infants and toddlers.Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Use of allergenically bioequivalent doses by parallel line bioassay to evaluate comparative safety and efficacy.Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.Graphical aid for determining power of clinical trials involving two groups.Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.JPEN Journal Club 22. Superiority, Noninferiority, and Equivalence.Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.Factors associated with the frequency of house calls by primary care physicians.Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.Sample size for clinical and biological research.Power and sample size calculations for clinical trials of myofascial pain of jaw muscles.The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.Underpowered and overbiased? Potentially unfair to the single-use bougie.
P2860
Q28193768-647B9A23-9104-47FB-BC87-919ECBF6DBC7Q28193975-9CEA3CAE-D99C-4BF1-B913-89D85FA8A0D9Q33555611-DB05E2E6-8A80-4047-B7B4-78903CBBE287Q33556582-884D72FB-6B89-428E-A230-6504E9DF1946Q33791044-E8E7EA2D-4965-4AD9-B6A8-A72A4305FD5EQ33976948-AD8E923C-7560-4594-A0BD-D38A8D40A769Q34137737-6628ECA1-3573-4355-BAE9-89EBD1BB40EDQ34264787-017A01D5-8B07-44D1-92CB-A52210B4CBB7Q34376404-A4478623-E370-4BBB-A455-E3A8D4A885D0Q34730558-BBECA372-7143-401A-84D6-DCDA4306EA3CQ34743117-8F194CC1-ED71-4ACA-BB45-572A7C8E2174Q35538285-C9AE1931-DF4D-44D4-96C5-387A3D62DCCAQ35575018-49C225F7-12D1-4077-9529-7FED1124B745Q35602757-5645CC08-55B5-412E-BA13-3881CD5BF522Q35817567-F1061553-7A24-4A0D-916C-882A8A52AF3FQ36070597-54A06792-CBD8-4BC5-B12B-40A6461F5857Q36754914-F3C521B9-BF87-4F32-828C-288F4F22C14EQ36923749-0DA0AD4C-1CD4-447C-90B0-8374F2DE8159Q37303448-C784550C-EB6F-4A46-B732-7F7F3F1FD4CBQ37977597-1A6BB673-37E7-4D08-B257-250138CF69C8Q37977613-F5FF62AF-4BCD-492C-8DD3-1FFF396BED40Q39190993-4509D1CD-ECA0-4888-B4C0-065E92EE6D2CQ39735590-5612E6BF-2B03-42CE-AED0-83ECB9A75D9AQ39827909-748633B7-FAD5-43D2-8F67-8DFE2B1C7EDEQ40458101-E208B613-5167-4F52-8C71-56DEBB664BE2Q40618745-89F7B913-5393-4DF4-B5B9-C8279409DDA0Q40634113-DEA8B084-B29B-4520-8410-3C40F7F2DE55Q40757872-285ABEAA-7810-48B7-B78A-E1B07FEFBD78Q40761947-AEED0E22-944E-492B-9415-ADB737F5AB28Q41892453-7F090FEE-95CA-48D9-8BAA-CB6167152F61Q43967973-E8270BDF-0350-4FBA-A5BA-F93D144924CDQ44013163-4DA6A9E2-E75A-437C-B68C-7C324A21CD94Q44136341-0CA2A1DF-837D-4263-A94D-E26C879CCB77Q44607979-C156C2A9-0168-4930-8633-70274C48EFD3Q45992355-10D45D93-8FC2-465E-8EB9-CC5CD28B70BAQ47174340-7978F11A-C0B5-4FB8-8C1E-D496DC8C9BD7Q47433997-35C46451-2155-4A01-A966-27D9F3C47C9AQ48274090-69E5FB75-5E08-41F7-8C90-4A0606ACEE54Q48834512-EC170A68-C97B-4070-85D9-41C1A5EC3875Q48924519-934F5508-B988-4E19-A5F0-B9D36792DD4A
P2860
Sample size nomograms for interpreting negative clinical studies.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Sample size nomograms for interpreting negative clinical studies.
@en
Sample size nomograms for interpreting negative clinical studies.
@nl
type
label
Sample size nomograms for interpreting negative clinical studies.
@en
Sample size nomograms for interpreting negative clinical studies.
@nl
prefLabel
Sample size nomograms for interpreting negative clinical studies.
@en
Sample size nomograms for interpreting negative clinical studies.
@nl
P2093
P1476
Sample size nomograms for interpreting negative clinical studies.
@en
P2093
P304
P356
10.7326/0003-4819-99-2-248
P407
P577
1983-08-01T00:00:00Z